Patients with acquired pure red cell aplasia respond to PI3Kdelta inhibitor rapidly. Wang Z, Jiang B, Song L, Sun M, et al. Am J Hematol 2024;99:1431-1433.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Z, Jiang B, Song L, Sun M, et al. Patients with acquired pure red cell aplasia respond to PI3Kdelta inhibitor rapidly. Am J Hematol 2024;99:1431-1433.
PMID: 38607227